Menopause affects roughly 1.3 million women in the United States each year. Most of those women are employed. The intersection of menopause and work has been one of the most persistently under-addressed dimensions of women’s health — not because the evidence is absent, but because the discomfort of discussing it has kept it off the policy agenda for decades.
That is changing. And it needs to change faster.
What the Workplace Ignores
The symptoms of menopause are not minor inconveniences. Hot flashes, sleep disruption, cognitive changes, joint pain, and mood variability can meaningfully affect work performance, attendance, and career trajectory. Women who are managing severe symptoms while working are often doing so without accommodation, without disclosure — because disclosure carries stigma — and without the clinical support that would make their experience manageable.
A survey published in the Menopause journal found that more than half of women experiencing menopausal symptoms reported that those symptoms had a negative impact on their work. A significant proportion had considered reducing their hours or leaving their jobs. The economic cost of that lost productivity — and of the talent attrition from workplaces that fail to support women in midlife — is substantial and almost entirely unmeasured.
The Clinical Gap
The situation is compounded by inadequate clinical support. Menopause care in the United States is fragmented, inconsistent, and often inaccessible.
Many primary care providers lack training in menopause management. Hormone therapy — the most evidence-based treatment for vasomotor symptoms — remains underutilized due to concerns that have been significantly revised since the initial Women’s Health Initiative findings were published in 2002. The WHI findings were widely misinterpreted to suggest that hormone therapy carried unacceptable risks; subsequent reanalysis and additional research have substantially reframed the risk-benefit profile, particularly for women who initiate therapy near the onset of menopause. Yet the chilling effect on prescribing persists.
Women who seek menopause care frequently describe experiences of being dismissed, undertreated, or told that their symptoms are an expected part of aging they should simply endure. That framing is not medically defensible. It is the health system’s discomfort with women’s midlife biology being displaced onto the patient.
A Workplace Policy Agenda
The Society for Women’s Health Research has developed comprehensive menopause workplace resource guides — one of the most practical available frameworks for employers and HR professionals. The core recommendations are actionable:
Organizational awareness. Leadership should acknowledge menopause as a health condition that affects employee experience, not a personal matter to be managed privately. Silence signals that disclosure is unsafe.
Flexible work arrangements. Schedule flexibility — particularly around timing of meetings, remote work options, and access to comfortable workspaces — can meaningfully reduce the workplace impact of symptoms.
Clinical support access. Employee benefit plans should include access to providers with demonstrated menopause management expertise. This requires both coverage design and network adequacy.
Manager training. Line managers who receive basic education about menopause — what it is, how it manifests, and how to respond to disclosure — are better equipped to provide appropriate support and less likely to make assumptions that harm career development.
The Policy Frame
What the United Kingdom has done — with the publication of national menopause workplace guidance and parliamentary attention to menopause as a workplace equality issue — is instructive. The U.S. is behind on this.
A federal legislative push to include menopause accommodations under existing workplace health and disability frameworks, combined with a EEOC guidance document addressing menopause-related discrimination, would provide the policy spine that voluntary employer action currently lacks.
The conversation has started. In clinical settings, in the media, and gradually in some workplaces, menopause is becoming discussable. The task now is to move from individual conversations to institutional change — and institutional change requires policy.
Women have been adapting to workplaces that ignore their health for long enough. It is the workplace’s turn to adapt.
